Business News • PR NewsWire • Genomic Health Announces Publication of Study Using Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated With Aromatase Inhibitors

Genomic Health Announces Publication of Study Using Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated With Aromatase Inhibitors

Genomic Health Announces Publication of Study Using Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated With Aromatase Inhibitors

REDWOOD CITY, Calif., March 8 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the publication of positive results from a large international study which demonstrated that the Oncotype DX® breast cancer Recurrence Score® (RS) result is a significant independent

View More : http://www.prnewswire.com/news-releases/genomic-health-announces-publication-of-study-using-oncotype-dxr-in-node-negativ...

Releted News by prnewswire

497 Highway Improvement Projects Underway or Completed in Illinois Thanks to Stimulus Law

7 Days Group Holdings Limited Announces Unaudited 2009 Fourth Quarter and Full Year Financial Results